To further evaluate the reliability of PLEGs prognostic prediction model, we categorized colon cancer patients based on several factors such as sex, age, stage, tumor location, Braf mutation, Kras mutation, and Tp53 mutation. This evidence concerns the gene BRAF and malignant colon neoplasm.